Jazz Pharmaceuticals
JAZZ
JAZZ
474 hedge funds and large institutions have $6.42B invested in Jazz Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 76 funds opening new positions, 162 increasing their positions, 158 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
474
Holders Change
+21
Holders Change %
+4.64%
% of All Funds
6.86%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.13%
New
76
Increased
162
Reduced
158
Closed
51
Calls
$28.9M
Puts
$15.9M
Net Calls
+$13.1M
Net Calls Change
+$2.52M
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$77.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$74.1M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$54.8M |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$32.5M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$31M |
Top Sellers
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$136M |
| 2 |
VPC
Vestal Point Capital
New York
|
-$66.8M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$65.8M |
| 4 |
BlackRock
New York
|
-$30.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$24M |
